What is the address of CABINET MEDICAL SOLANGE CRAENEN?

The registered office of CABINET MEDICAL SOLANGE CRAENEN is located at Chaussée Brunehaut 6, 4452 Juprelle.

Is CABINET MEDICAL SOLANGE CRAENEN still active?

Yes. According to the CBE (31 October 2026) CABINET MEDICAL SOLANGE CRAENEN is active, legal situation “Normale toestand”, started on 13 July 2018.

Is CABINET MEDICAL SOLANGE CRAENEN registered on Peppol?

No, CABINET MEDICAL SOLANGE CRAENEN is currently not registered on the Peppol network.

What is the enterprise number of CABINET MEDICAL SOLANGE CRAENEN?

The enterprise number of CABINET MEDICAL SOLANGE CRAENEN is BE0699901223.

When was CABINET MEDICAL SOLANGE CRAENEN founded?

CABINET MEDICAL SOLANGE CRAENEN was founded on 13 July 2018.

Who are the directors of CABINET MEDICAL SOLANGE CRAENEN?

According to the 2025 annual accounts, the directors of CABINET MEDICAL SOLANGE CRAENEN are: Solange CRAENEN.

Is CABINET MEDICAL SOLANGE CRAENEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 July 2018; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did CABINET MEDICAL SOLANGE CRAENEN make in 2025?

CABINET MEDICAL SOLANGE CRAENEN posted a profit after taxes of € 105,313 in financial year 2025.

What is the revenue of CABINET MEDICAL SOLANGE CRAENEN?

As a small company, CABINET MEDICAL SOLANGE CRAENEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 138,887.

CABINET MEDICAL SOLANGE CRAENEN (Private Limited)

Dossier CABINET MEDICAL SOLANGE CRAENEN, printed on 1 November 2026 from databakkes.be/en/0699901223/cabinet-medical-solange-craenen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

CABINET MEDICAL SOLANGE CRAENEN from Juprelle, company number BE0699901223, closed financial year 2025 with a result of € 105,313 after tax. For that financial year CABINET MEDICAL SOLANGE CRAENEN recorded a gross margin of € 138,887 and equity of € 430,166. Compared with financial year 2024, the result moved from € 116,816 to € 105,313. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 11, 2026.

What it is worth Growing

€ 430,166

▲ 23% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 105,313

▼ 10% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 213,699

▲ 190% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 24,390 paid out

23 % of the profit went to the shareholders, the rest stayed in the company.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,478

▲ 80% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 1,178

▼ 91% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 123,291 Gross margin 2022: € 123,291 First fiscal year in the series	€ 90,611 Gross margin 2023: € 90,611 ▼ 27% vs 2022 (€ 123,291) Unfavourable step	€ 155,043 Gross margin 2024: € 155,043 ▲ 71% vs 2023 (€ 90,611) Favourable step	€ 138,887 Gross margin 2025: € 138,887 ▼ 10% vs 2024 (€ 155,043) Unfavourable step	▼ 10%
Profit after taxes	€ 93,333 Profit after taxes 2022: € 93,333 First fiscal year in the series	€ 67,241 Profit after taxes 2023: € 67,241 ▼ 28% vs 2022 (€ 93,333) Unfavourable step	€ 116,816 Profit after taxes 2024: € 116,816 ▲ 74% vs 2023 (€ 67,241) Favourable step	€ 105,313 Profit after taxes 2025: € 105,313 ▼ 10% vs 2024 (€ 116,816) Unfavourable step	▼ 10%
Equity	€ 245,372 Equity 2022: € 245,372 First fiscal year in the series	€ 248,225 Equity 2023: € 248,225 ▲ 1% vs 2022 (€ 245,372) Favourable step	€ 349,244 Equity 2024: € 349,244 ▲ 41% vs 2023 (€ 248,225) Favourable step	€ 430,166 Equity 2025: € 430,166 ▲ 23% vs 2024 (€ 349,244) Favourable step	▲ 23%
Total debts	€ 34,705 Total debts 2022: € 34,705 First fiscal year in the series	€ 87,231 Total debts 2023: € 87,231 ▲ 151% vs 2022 (€ 34,705) Unfavourable step	€ 28,863 Total debts 2024: € 28,863 ▼ 67% vs 2023 (€ 87,231) Favourable step	€ 28,046 Total debts 2025: € 28,046 ▼ 3% vs 2024 (€ 28,863) Favourable step	▼ 3%
Cash	€ 196,047 Cash 2022: € 196,047 First fiscal year in the series	€ 221,196 Cash 2023: € 221,196 ▲ 13% vs 2022 (€ 196,047) Favourable step	€ 73,780 Cash 2024: € 73,780 ▼ 67% vs 2023 (€ 221,196) Unfavourable step	€ 213,699 Cash 2025: € 213,699 ▲ 190% vs 2024 (€ 73,780) Favourable step	▲ 190%
Retained profit	€ 232,972 Retained profit 2022: € 232,972 First fiscal year in the series	€ 229,625 Retained profit 2023: € 229,625 ▼ 1% vs 2022 (€ 232,972) Unfavourable step	€ 330,644 Retained profit 2024: € 330,644 ▲ 44% vs 2023 (€ 229,625) Favourable step	€ 411,566 Retained profit 2025: € 411,566 ▲ 24% vs 2024 (€ 330,644) Favourable step	▲ 24%
Dividend	€ 23,529 Dividend 2022: € 23,529 First fiscal year in the series	€ 70,588 Dividend 2023: € 70,588 ▲ 200% vs 2022 (€ 23,529) Unchanged	€ 17,647 Dividend 2024: € 17,647 ▼ 75% vs 2023 (€ 70,588) Unchanged	€ 24,390 Dividend 2025: € 24,390 ▲ 38% vs 2024 (€ 17,647) Unchanged	▲ 38%
Balance sheet total	€ 280,077 Balance sheet total 2022: € 280,077 First fiscal year in the series	€ 335,456 Balance sheet total 2023: € 335,456 ▲ 20% vs 2022 (€ 280,077) Unchanged	€ 378,107 Balance sheet total 2024: € 378,107 ▲ 13% vs 2023 (€ 335,456) Unchanged	€ 458,213 Balance sheet total 2025: € 458,213 ▲ 21% vs 2024 (€ 378,107) Unchanged	▲ 21%

Key figures of CABINET MEDICAL SOLANGE CRAENEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to CABINET MEDICAL SOLANGE CRAENEN?

What happened at CABINET MEDICAL SOLANGE CRAENEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 11, 2026 New annual accounts for financial year 2025: profit of € 105,313 (▼ 10% vs 2024). filed late Source: NBB ↗
Jul 13, 2018 New establishment in Juprelle. KBO
Jul 13, 2018 Start of the company according to the CBE. KBO

In short

From € 93,333 profit in 2022 to € 105,313 profit in 2025.

Paid € 113,077 in corporate taxes since 2022.

Best year ever: 2024, with € 116,816 profit.

Paid out € 136,155 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Solange CRAENEN

CABINET MEDICAL SOLANGE CRAENEN

Behind CABINET MEDICAL SOLANGE CRAENEN is Solange CRAENEN.

Directors

According to the 2025 annual accounts

Solange CRAENEN

Manager

Establishments

Establishment units

Physical locations of this company

Registered office

Chaussée Brunehaut 6

4452 Juprelle

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0699.901.223
VAT number: BE 0699.901.223
Registered office: Chaussée Brunehaut 6, 4452 Juprelle
Names & denominations: CABINET MEDICAL SOLANGE CRAENEN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 13 July 2018
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗